newsfilter
← Latest News
GlobeNewswire·

Nasus Pharma Announces Closing of $15.0 Million Private Placement

TEL AVIV, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE:NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal